i2C Solutions, LLC

Medtech

Topical supersaturated oxygen emulsion (SOE) therapy for treating traumatic eye injury

i2csolutions.com →
Grants
$2.0M
4 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
5
2 granted · 3 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Defense · Phase I · Stable Maneuverable Airborne Thermal Management for Directed Energy Systems$124,972
Federal grantDepartment of Defense · Phase II · Conformal Thermal Ground Plane for Fiber Amplifier$749,321
Federal grantNational Aeronautics and Space Administration · Phase I · Flexible 2-Phase Thermal Strap for Small Sats$124,981
Federal grantDepartment of Defense · Phase II · Supersaturated Oxygen Emulsion for Topical Treatment of Ocular Trauma$975,680
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2255GLYCIOME, LLC——
2256SUPERFLUID DX, INC.——
2257Cell-Safe Life Sciences LLC——
2258i2C Solutions, LLC——
2259FEMTOVOX INCORPORATED——
2260ATHEM L.L.C.——
2261OMNISCIENT IMAGING INC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 2 granted of 5

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.